Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)
CNY 20.23
(-6.86%)
CNY 20.23
(-6.86%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.03 Billion CNY | 49.3% |
| 2022 | 2.03 Billion CNY | 148.62% |
| 2021 | 817.76 Million CNY | -71.55% |
| 2020 | 2.87 Billion CNY | 20.56% |
| 2019 | 2.38 Billion CNY | 283.88% |
| 2018 | 621.01 Million CNY | 138.85% |
| 2017 | 260 Million CNY | 17151.63% |
| 2016 | 1.5 Million CNY | 69.05% |
| 2015 | 891.51 Thousand CNY | -98.36% |
| 2014 | 54.37 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 8 Million CNY | 60.0% |
| 2008 | 5 Million CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 8.98 Billion CNY | 130.74% |
| 2024 Q1 | 5.03 Billion CNY | 65.91% |
| 2024 Q2 | 3.9 Billion CNY | -22.53% |
| 2023 Q4 | 3.03 Billion CNY | -29.99% |
| 2023 Q1 | 4.09 Billion CNY | 101.18% |
| 2023 FY | 3.03 Billion CNY | 49.3% |
| 2023 Q2 | 3.16 Billion CNY | -22.61% |
| 2023 Q3 | 4.33 Billion CNY | 36.98% |
| 2022 Q3 | 2.05 Billion CNY | -25.0% |
| 2022 Q2 | 2.74 Billion CNY | 13.56% |
| 2022 FY | 2.03 Billion CNY | 148.62% |
| 2022 Q1 | 2.41 Billion CNY | 195.25% |
| 2022 Q4 | 2.03 Billion CNY | -1.13% |
| 2021 FY | 817.76 Million CNY | -71.55% |
| 2021 Q3 | 573.91 Million CNY | -67.94% |
| 2021 Q4 | 817.76 Million CNY | 42.49% |
| 2021 Q2 | 1.79 Billion CNY | -52.05% |
| 2021 Q1 | 3.73 Billion CNY | 29.89% |
| 2020 Q2 | 3.36 Billion CNY | -8.63% |
| 2020 Q4 | 2.87 Billion CNY | -19.49% |
| 2020 FY | 2.87 Billion CNY | 20.56% |
| 2020 Q1 | 3.68 Billion CNY | 54.61% |
| 2020 Q3 | 3.56 Billion CNY | 6.01% |
| 2019 Q2 | 1.71 Billion CNY | 15.96% |
| 2019 Q4 | 2.38 Billion CNY | -3.74% |
| 2019 FY | 2.38 Billion CNY | 283.88% |
| 2019 Q1 | 1.48 Billion CNY | 138.74% |
| 2019 Q3 | 2.47 Billion CNY | 44.05% |
| 2018 Q3 | 840.39 Million CNY | 38.79% |
| 2018 FY | 621.01 Million CNY | 138.85% |
| 2018 Q4 | 621.01 Million CNY | -26.11% |
| 2018 Q2 | 605.51 Million CNY | 101.84% |
| 2018 Q1 | 300 Million CNY | 15.38% |
| 2017 Q2 | 260 Million CNY | 0.0% |
| 2017 Q3 | 260 Million CNY | 0.0% |
| 2017 Q4 | 260 Million CNY | 0.0% |
| 2017 FY | 260 Million CNY | 17151.63% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q4 | 1.5 Million CNY | 0.0% |
| 2016 FY | 1.5 Million CNY | 69.05% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 Q3 | - CNY | -100.0% |
| 2015 FY | 891.51 Thousand CNY | -98.36% |
| 2015 Q1 | 54.37 Million CNY | 0.0% |
| 2015 Q2 | 54.37 Million CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2014 Q4 | 54.37 Million CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | 54.37 Million CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q3 | - CNY | -100.0% |
| 2011 Q2 | 122.25 Million CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 Q4 | 8 Million CNY | 0.0% |
| 2009 FY | 8 Million CNY | 60.0% |
| 2008 FY | 5 Million CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |